Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

NCT07732712 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Isatuximab
DRUG: VRD

Sponsor

The Affiliated People's Hospital of Ningbo University